Comparative aquatic toxicity of propranolol and its photodegraded mixtures: Algae and rotifer screening

Environmental Toxicology and Chemistry

Volumn 28, Issue 12, 2009, Pages 2622-2631

  Liu, Qin Tao ^a   Williams, Tim D ^a   Cumming, Rob I ^a   Holm, Gisela ^b   Hetheridge, Malcolm J ^a   Murray Smith, Richard ^a  

^a ASTRAZENECA   (United Kingdom)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Ecotoxicity; Environmental depletion; Mixtures; Pharmaceuticals; Transformation products

Indexed keywords

ACTIVE PHARMACEUTICAL INGREDIENTS; AQUATIC SPECIES; AQUATIC TOXICITY; BRACHIONUS; COMPARATIVE TOXICITY; DEPLETION MECHANISM; ECOTOXICITY; ENVIRONMENTAL RISK ASSESSMENT; FAST REACTION; HUMAN METABOLISMS; PARENT COMPOUNDS; PHOTOTRANSFORMATIONS; PSEUDOKIRCHNERIELLA SUBCAPITATA; RECEIVING WATERS; RIVER WATER; SCREENING TESTS; SOLAR SIMULATOR; TEST SOLUTIONS; TRANSFORMATION PRODUCTS;

AQUACULTURE; CHEMICAL COMPOUNDS; DEIONIZED WATER; DRUG PRODUCTS; MIXTURES; RATE CONSTANTS; RISK ASSESSMENT; RISK MANAGEMENT; SEWAGE; SEWAGE TREATMENT; SEWAGE TREATMENT PLANTS; SURFACE REACTIONS; WATER POLLUTION CONTROL;

TOXICITY;

PROPRANOLOL; RIVER WATER; SURFACE WATER;

ALGA; CONCENTRATION (COMPOSITION); DRUG; ECOTOXICOLOGY; HYPOTHESIS TESTING; INVERTEBRATE; METABOLISM; PHOTODEGRADATION; TOXICITY TEST; TRANSFORMATION;

ALGA; AQUATIC ENVIRONMENT; AQUATIC SPECIES; ARTICLE; BRACHIONNUS CALYCIFLORUS; COMPARATIVE TOXICOLOGY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG TRANSFORMATION; ECOTOXICITY; NONHUMAN; PHOTODEGRADATION; PRIORITY JOURNAL; PSEUDOKIRCHNERIELLA SUBCAPITATA; REACTION TIME; RISK ASSESSMENT; ROTIFERA; SCREENING TEST; TOXICITY TESTING;

ALGAE; ANIMALS; FEMALE; PHOTOLYSIS; PROPRANOLOL; RIVERS; ROTIFERA; WATER POLLUTANTS, CHEMICAL;

ALGAE; BRACHIONUS CALYCIFLORUS; SELENASTRUM CAPRICORNUTUM;

EID: 73449121951     PISSN: 07307268     EISSN: None     Source Type: Journal    
DOI: 10.1897/09-071.1     Document Type: Article

References (52)

1. Daughton CG, Ruhoy IS. 2008. The afterlife of drugs and the role of Pharm-Ecovigilance. Drug Saf 31:1069-1082.
2. Johnson AC, Jurgens MD, Williams RJ, Kumerrer K, Kortenkamp A, Sumpter JP. 2008. Do cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment and human health? An overview and UK case study. J Hydrol 348:167-175.
3. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT. 2002. Pharmaceuticals, hormones and other organic wastewater contaminants in US streams, 1999-2000: A national reconnaissance. Environ Sci Technol 36:1202-1211.
4. Ternes TA. 1998. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32:3245-3863.
5. Bendz D, Paxéus NA, Ginn TR, Loge FJ. 2005. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. J Hazard Mater 122:195-204.
6. Peng X, Yu Y, Tang C, Tan J, Huang Q, Wang Z. 2008. Occurrence of steroid estrogens, endocrine-disruption phenols and acid pharmaceutical residues in urban riverine water of the Pearl River Delta, South China. Sci Total Environ 397:158-166.
7. Cunningham VL, Buzby M, Hutchinson T, Mastrocco F, Parke N, Roden N. 2006. Effects of human pharmaceuticals on aquatic life: Next steps. Environ Sci Technol 40:3456-3462.
8. Sedlak DL, Pinkston KE. 2001. Factors affecting the concentrations of pharmaceuticals released to the aquatic environment. Water Resources Update 120:56-64.
9. Lam MW, Young CJ, Brain RA, Johnson DJ, Hanson MA, WUson CJ, Richards SM, Solomon KR, Mabury SA. 2004. Aquatic persistence of eight pharmaceuticals in a microcosm study. Environ Toxicol Chem 23:1431-1440.
10. Huber MM, Göbel A, Joss A, Hermann D, Löffler D, McArdell CS, Ried A, Siegrist H, Ternes TA, Gunten UV. 2005. Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: A pilot study. Environ Sci Technol 39:4290-4299.
11. Kinney CA, Furlong ET, Werner SL, Cahill JD. 2006. Presence and distribution of wastewater-derived pharmaceuticals in soil irrigated with reclaimed water. Environ Toxicol Chem 25:317-326.
12. Castegnaro M, Hansel S. 2006. Antineoplastic drugs in sewage from hospitals and households. Environ Risques Santé 5:266-270.
13. Joss A, Zabczynski S, Göbel A, Hoffmann B, Löffler D, McArdell CS, Ternes TA, Thomsen A, Siegrist H. 2006. Biological degradation of pharmaceuticals in municipal wastewater treatment: Proposing a classification scheme. Water Res 40:1686-1696.
14. Huggett DB, Brooks BW, Peterson B, Foran CM, Schlenk D. 2002. Toxicity of select beta-adrenergic receptor blocking pharmaceuticals (β-blockers) on aquatic organisms. Arch Environ Contam Toxicol 43:229-235.
15. Escher BI, Bramaz N, Richter M, Lienert J. 2006. Comparative ecotoxicological hazard assessment of β-blockers and their human metabolites using a mode-of-action-based test battery and a QSAR approach. Environ Sci Technol 40:7402-7408.
16. Daughton CG, Ternes TA. 1999. Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environ Health Perspect 107:907-937.
17. Public Employees for Environmental Responsibility. 2008. EPA dropped ball on pharmaceuticals in drinking water. News Release, March 19, 2008. Washington, DC.
18. European Medicines Agency. 2006. Guideline on the environmental risk assessment of medicinal products for human use. Document reference EMEA/CHMP/SWP/4447/00. Committee for Medicinal Products for Human Use, London, UK.
19. Hutchinson TH, Caldwell D, Hartmann A, Huggett D, Mastrocco F, Maund S, Oberwalder C, Versteeg D, Holt M, Galay Burgos M. 2007. Intelligent testing strategies in ecotoxicity: Mode of action approach for specifically acting chemicals. Technical Report 102. European Centre for Ecotoxicology and Toxicity of Chemicals, Brussels, Switzerland.
20. Andreozzi R, Raffaele M, Nicklas P. 2003. Pharmaceuticals in STP effluents and their solar photodegration in aquatic environment. Chemosphere 50:1319-1330.
21. Chiron S, Minero C, Vione D. 2006. Photodegradation processes of the antiepileptic drug carbamazepine, relevant to estuarine waters. Environ Sci Technol 40:5977-5983.
22. Werner JJ, McNeill K, Arnold WA. 2005. Environmental photodegradation of mefenamic acid. Chemosphere 58:1339-1346.
23. Buser H-R, Poiger T, Müller MD. 1998. Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: Rapid photodegradation in a lake. Environ Sci Technol 32:3449-3456.
24. Liu Q, WUliams HE. 2007. Kinetics and degradation products for direct photolysis of β-blockers in water. Environ Sci Technol 41:803-810.
25. Robinson PF, Liu Q-T, Riddle AM, Murray-Smith R. 2007. Modeling the impact of direct phototransformation on predicted environmental concentrations (PECs) of propranolol hydrochloride in UK and US rivers. Chemosphere 66:757-766.
26. Liu Q-T, Riddle AM, Robinson PF, Gray N. 2004. Roles of partitioning and phototransformation in predicting the fate and movement of pharmaceuticals in UK and US rivers. Proceedings, 4th International Conference Pharma EDCs, National Ground Water Association, Minneapolis, MN, USA, October 13-15, pp 48-62.
27. Lin AY-C, Reinhard M. 2005. Photodegradation of common environmental pharmaceuticals and estrogens in river water. Environ Toxicol Chem 24:1303-1309.
28. Liu Q-T, Cumming RI, Sharpe AD. 2009. Photo-induced environmental depletion processes of β-blockers in river waters. Photochem Photobiol Sci 8:768-777.
29. Cunningham VL, Constable DJC, Hannah RE. 2004. Environmental risk assessment of paroxetine. Environ Sci Technol 38:3351-3359.
30. DellaGreca M, Fiorentino A, Iesce MR, Isidori M, Nardelli A, Previtera L, Temussi F. 2003. Identification of phototransformation products of prednisone by sunlight: Toxicity of the drug and its derivatives on aquatic organisms. Environ Toxicol Chem 22: 534-639.
31. DellaGreca M, Iesce MR, Isidori M, Nardelli A, Previtera L, Rubino M. 2007. Phototransformation products of tamoxifen by sunlight in water: Toxicity of the drug and its derivatives on aquatic organisms. Chemosphere 67:1933-1939.
32. DellaGreca M, Fiorentino A, Isidori M, Lavorgna M, Previtera L, Rubino M, Temussi F. 2004. Toxicity of prednisolone, dexamethasone and their photochemical derivatives on aquatic organisms. Chemosphere 54:629-637.
33. DellaGreca M, Brigante M, Isidori M, Nardelli A, Previtera L, Rubino M, Temussi F. 2004. Phototransformation and ecotoxicity of the drug Naproxe-Na. Environ Chem Lett 1:237-241.
34. Isidori M, Nardelli A, Parrella A, Pascarella L, Previtera L. 2006. A multispecies study to assess the toxic and genotoxic effect of pharmaceuticals: Furosemide and its photoproduct. Chemosphere 63:785-793.
35. Nalecz-Jawecki G, Hajnas A, Sawicki J. 2007. Photodegradation and phototoxicity of thioridazine and chlorpromazine evaluated with chemical analysis and aquatic organisms. Ecotoxicology 17:13-20.
36. Schmitt-Jansen M, Bartels P, Adler N, Altenburger R. 2007. Phytotoxicity assessment of diclofenac and its phototransformation products. Anal Bioanal Chem 387:1389-1396.
37. Organization for Economic Cooperation and Development. 2008. Phototransformation of chemicals in water - Direct photolysis. Guideline 316. Paris, France.
38. Panter GH, Hutchings M, Hutchinson TH. 2005. Development of rapid screening assays with algae and daphnids for application in pharmaceutical manufacturing environmental assessments. Abstracts, SETAC Europe 15th Annual Meeting, SETAC, Lille, France, May 22-26, p 159.
39. Organizations for Economic Cooperation and Development. 2006. Freshwater alga and cyanobacteria, growth inhibition test. Guideline 201. Paris, France.
40. International Organization for Standardization. 2007. Draft International Standard ISO/DIS 20666, Water quality - Determination of the chronic toxicity to Brachionus calyciflorus in 48 h. Geneva, Switzerland.
41. 10: Determination of Hposomal membrane-water partition coefficients of ionisable drugs. Pharmacol Res 15:209-215.
42. Ferrari B, Mons R, Vollat B, Fraysse B, Paxeus N, Lo Giudice R, Pollio A, Garric J. 2004. Environmental risk assessment of six human pharmaceuticals: Are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment? Environ Toxicol Chem 23:1344-1354.
43. Owen SF, Huggett DB, Hutchinson TH, Hetheridge MJ, Kinter LB, Ericson JF, Sumpter JP. 2009. Uptake of propranolol, a cardiovascular pharmaceutical, from water into fish plasma and its effects on growth and organ biometry. Aquat Toxicol 93:217-224.
44. Doggrell SA. 1990. The membrane stabilizing and betal-adrenoceptor blocking activity of (+)- and (-)-propranolol on the rat left atria. Gen Pharmacol Vasc Sci 21:677-680.
45. Fent K, Weston AA, Caminada D. 2006. Ecotoxicity of human pharmaceuticals. Aquat Toxicol 76:122-159.
46. Riedl J, Altenburger R. 2007. Physicochemical substance properties as indicators for unreliable exposure in microplate-based bioassays. Chemosphere 67:2210-2220.
47. Eisentraeger A, Dott W, Klein J, Hahn S. 2003. Comparative studies on algal toxicity testing using fluorometric microplate and Erlenmeyer flask growth-inhibition assays. Ecotoxicol Environ Saf 54:346-354.
48. Uwai K, Tani M, Ohtake Y, Abe S, Maruko A, Chiba T, Hamaya Y, Ohkubo Y, Takeshita M. 2005. Photodegradation products of propranolol: The structures and pharmacological studies. Life Sci 78:357-365.
49. Piram A, Salvador A, Verne C, Herbreteau B, Faure R. 2008. Photolysis of β-blockers in environmental waters. Chemosphere 73:1265-1271.
50. Kortenkamp A. 2007. Ten years of mixing cocktails: a review of combination effects of endocrine disrupting chemicals. Environ Health Perspect U5(Suppl. 1):98-105.
51. Williams TD, Caunter JE, Lillicrap AD, Hutchinson TH, Gillings EG, Duffell S. 2007. Evaluation of the reproductive effects of tamoxifen citrate in partial and full life-cycle studies using fathead minnows (Pimephales promelas). Environ Toxicol Chem 26:695-707.
52. Owen SF, Giltrow E, Huggett DB, Hutchinson TH, Saye J, Winter MJ, Sumpter JP. 2007. Comparative physiology, pharmacology and toxicology of β-blockers: Mammals versus fish. Aquat Toxicol 82:145-162.